Skip to content
case study
CLINICAL CASE: PATIENT WITH HEPATOSTEATOSIS AND DYSPLIDEMIA
Treated with Icarus 30cpr
Dr. Gennaro Marino
Medical Surgeon
Specialized in Internal Medicine
ASL NAPLES 1 CENTER
Patient M.T. born in Naples on 01/30/1960, registered at our center with cc no. 14135
Medical history: Hepatosteatosis, Diabetes mellitus type 2, Hypertension, Mixed dyslipidemia.
At the time of the visit on 18/01/22 the patient is On therapy with: Metformin 500 mg twice a day, Enalapril 10mg in the morning.
Although the treating physician has prescribed statin therapy several times, the patient has always refused for fear of the side effects listed on the internet.
The lipid profile noted at the visit on 02/18/22 is shown in the first column of the table. In addition, the patient with hepatosteatosis reports abdominal bloating and aerophagia.
On this date, therapy is prescribed with ICARO 30cpr, 1 cp in the evening, made aware of the easy tolerability of the same.
Follow-up visit on 5/31/22: Analyzed lipid profile detected at the visit, shown in column #2 of the table.
CONCLUSIONS: To date, current therapy continues happily, even with marked reduction in abdominal bloating and aerophagia. Good overall clinical condition. Hb glycosisIata: 6.1%.
Data were extracted from the patient’s medical records.
Dr. Gennaro Marino
Share the article on your socials!
Stay up to date*, sign up for our Science Newsletter to receive every article on your email!
You may also be interested in.
-
STUDIO SU UN NUTRACEUTICO ED UNA LOZIONE FITOTERAPICA IN DONNE CON ALOPECIA FEMMINILE POST-MENOPAUSA -
THE USE OF GINKGO BILOBA EXTRACT IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME -
ON THE USE OF SPECIFIC NUTRACEUTICALS AS ADJUNCTS TO TREATMENTS FOR ADHD -
THEY TALK ABOUT TRIVIS UV ON “THE SKIN” -
ON THE BENEFITS OF HYALURONIC ACID ON SCALP AND FOLLICLES
Products in this article:
Icarus
Icaro 30cpr is a state-of-the-art nutraceutical specifically for the treatment of hepatic steatosis and high cholesterol levels.
